FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to isoxazoline FAAH inhibitors of formula (I) or their pharmaceutically acceptable forms, wherein each of G, Ra, Rb, Rc and Rd has a value described in the present application, to pharmaceutical compositions, and methods of treating a FAAH-mediated condition.
EFFECT: developing the method of treating the FAAH-mediated condition.
32 cl, 22 tbl, 351 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696275C1 |
INTERMEDIATE COMPOUNDS AND METHODS FOR PREPARING ZEARALENE MACROLIDE ANALOGUES | 2008 |
|
RU2478630C2 |
SOMATOSTATIN RECEPTOR ANTAGONISTS AND METHODS FOR USING THEM | 2017 |
|
RU2740464C2 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2697090C1 |
NOVEL CONJUGATES OF CC-1065 ANALOGUES AND BIFUNCTIONAL LINKERS | 2011 |
|
RU2578719C9 |
PYRIMIDINE DERIVATIVES AND USE THEREOF IN TREATING RESPIRATORY DISEASES, SUCH AS COPD | 2011 |
|
RU2604719C2 |
IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ACID ESTER AS AGONIST, ITS PREPARATION AND USE | 2020 |
|
RU2812182C1 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
NOVEL CC-1065 ANALOGUES AND THEIR CONJUGATES | 2009 |
|
RU2562232C2 |
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
Authors
Dates
2015-01-20—Published
2010-05-18—Filed